PHILADELPHIA, PA — IntegriChain has announced that its pharmaceutical pricing and regulatory experts will take the stage at the upcoming Medicaid Drug Rebate Reporting Summit 2024, scheduled from September 23 to 25 in Chicago, IL. The event will feature two crucial sessions led by the company’s thought leaders.
On September 24, from 10:55 am to 11:35 am, Jeff Baab, Partner, Advisory Services at IntegriChain, and Kristin Hicks, Partner at Arnold and Porter, will delve into the topic “IRA Negotiation: Insights, Potential Implications, and Best Practices for Preparation.” They will provide a detailed analysis of what the final Maximum Fair Prices (MFPs) indicate regarding CMS discount justification and share strategies for negotiation processes, focusing on documentation and data requirements.
Later that day, from 2:50 pm to 3:30 pm, Jake Keenan, Vice President of GP Managed Services, Federal Compliance Solutions, will lead a session on “Taking Action on the IRA – Operationalizing the Upcoming New Rebates of the IRA and Discarded Drug Refunds.” Keenan will guide pharmaceutical manufacturers on preparing for new rebates under the Inflation Reduction Act, addressing operational challenges and necessary adjustments to rebate systems.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.